February 2024
1. LEE ZS, Ryan N
   Intravascular imaging in percutaneous coronary intervention.
   Lancet. 2024 Feb 21:S0140-6736(23)02686-7. doi: 10.1016/S0140-6736(23)02686.
   

   >> Share

   
   
2. STONE GW, Christiansen EH, Ali ZA, Andreasen LN, et al
   Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis.
   Lancet. 2024 Feb 21:S0140-6736(23)02454-6. doi: 10.1016/S0140-6736(23)02454.
   

   >> Share

   
   
3. CONSOLI A, Gory B
   Long-term results of mechanical thrombectomy for large ischaemic stroke.
   Lancet. 2024 Feb 8:S0140-6736(24)00158-2. doi: 10.1016/S0140-6736(24)00158.
   

   >> Share

   
   
4. SARRAJ A, Abraham MG, Hassan AE, Blackburn S, et al
   Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial.
   Lancet. 2024 Feb 8:S0140-6736(24)00050-3. doi: 10.1016/S0140-6736(24)00050.
   

   >> Share

   
   January 2024
5. LANDI A, Pedrazzini G, Wild L, Beele A, et al
   Coronary embolisation of native aortic valve debris during transcatheter aortic valve replacement: mechanical embolectomy and histopathological analysis.
   Lancet. 2024;403:e5-e6.
   

   >> Share

   
   December 2023
6. JIMENEZ DIAZ VA, Iniguez Romo A
   Intracoronary artery visualisation of crystalline sirolimus deposits after drug-coated balloon angioplasty for acute coronary syndrome.
   Lancet. 2023;402:2111-2112.
   

   >> Share

   
   October 2023
7. IGLESIAS JF, Roffi M, Losdat S, Muller O, et al
   Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial.
   Lancet. 2023 Oct 25:S0140-6736(23)02197-9. doi: 10.1016/S0140-6736(23)02197.
   

   >> Share

   
   
8. BUITEN RA, Ploumen EH
   Drug-eluting stents for ST-segment elevation myocardial infarction: extending the biodegradable versus durable polymer debate.
   Lancet. 2023 Oct 25:S0140-6736(23)02297-3. doi: 10.1016/S0140-6736(23)02297.
   

   >> Share

   
   
9. DIPPEL DWJ, Roozenbeek B
   Thrombectomy for acute ischaemic stroke without advanced imaging.
   Lancet. 2023 Oct 10:S0140-6736(23)02229-8. doi: 10.1016/S0140-6736(23)02229.
   

   >> Share

   
   
10. BENDSZUS M, Fiehler J, Subtil F, Bonekamp S, et al
    Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial.
    Lancet. 2023 Oct 10:S0140-6736(23)02032-9. doi: 10.1016/S0140-6736(23)02032.
    

    >> Share

    
    August 2023
11. HANKEY GJ
    Does thrombolysis add value to thrombectomy for acute ischaemic stroke?
    Lancet. 2023 Aug 25:S0140-6736(23)01202-3. doi: 10.1016/S0140-6736(23)01202.
    

    >> Share

    
    May 2023
12. KALRA A, Kumar A
    Endovascular reperfusion strategy for infra-popliteal chronic limb threatening ischaemia.
    Lancet. 2023;401:1749-1750.
    

    >> Share

    
    
13. BRADBURY AW, Moakes CA, Popplewell M, Meecham L, et al
    A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisatio
    Lancet. 2023;401:1798-1809.
    

    >> Share

    
    April 2023
14. GAUDINO M, Andreotti F, Kimura T
    Current concepts in coronary artery revascularisation.
    Lancet. 2023 Apr 27:S0140-6736(23)00459-2. doi: 10.1016/S0140-6736(23)00459.
    

    >> Share

    
    
15. WARDLAW JM
    Even more benefit with endovascular treatment for patients with acute ischaemic stroke: MR CLEAN-LATE.
    Lancet. 2023;401:1317-1319.
    

    >> Share

    
    March 2023
16. DILETTI R, den Dekker WK, Bennett J, Schotborgh CE, et al
    Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.
    Lancet. 2023 Mar 3:S0140-6736(23)00351-3. doi: 10.1016/S0140-6736(23)00351.
    

    >> Share

    
    
17. PUSTJENS TFS, Vriesendorp PA, Van't Hof AWJ
    Revascularisation in acute coronary syndromes: change in practice?
    Lancet. 2023 Mar 3:S0140-6736(23)00403-8. doi: 10.1016/S0140-6736(23)00403.
    

    >> Share

    
    November 2022
18. YANG P, Song L, Zhang Y, Zhang X, et al
    Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
    Lancet. 2022;400:1585-1596.
    

    >> Share

    
    
19. MISTRY EA, Nguyen TN
    Blood pressure goals after mechanical thrombectomy: a moving target.
    Lancet. 2022;400:1558-1559.
    

    >> Share

    
    
20. LI Y, Liang Z, Qin L, Wang M, et al
    Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)01999.
    

    >> Share

    
    August 2022
21. GANESAN V, Kartik V, Alex A
    No clubbing in the fingers, only in the toes: patent ductus arteriosus and reversed shunting.
    Lancet. 2022;400:522.
    

    >> Share

    
    July 2022
22. KHATRI P
    Intravenous thrombolysis before thrombectomy for acute ischaemic stroke.
    Lancet. 2022;400:76-78.
    

    >> Share

    
    
23. MITCHELL PJ, Yan B, Churilov L, Dowling RJ, et al
    Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4.5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial.
    Lancet. 2022;400:116-125.
    

    >> Share

    
    
24. FISCHER U, Kaesmacher J, Strbian D, Eker O, et al
    Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial.
    Lancet. 2022;400:104-115.
    

    >> Share

    
    March 2022
25. HALLIDAY A, Bulbulia R, Bonati LH, Chester J, et al
    Is stenting equivalent to endarterectomy for asymptomatic carotid stenosis? - Authors' reply.
    Lancet. 2022;399:1116.
    

    >> Share

    
    
26. ABBOTT AL, Wijeratne T, Zeebregts CJ, Ricco JB, et al
    Is stenting equivalent to endarterectomy for asymptomatic carotid stenosis?
    Lancet. 2022;399:1115-1116.
    

    >> Share

    
    
27. KAMTCHUM-TATUENE J, Jickling GC
    Is stenting equivalent to endarterectomy for asymptomatic carotid stenosis?
    Lancet. 2022;399:1114-1115.
    

    >> Share

    
    February 2022
28. ALMEKHLAFI MA, Coutts SB
    Anti-thrombotics cause harm in the setting of stroke thrombectomy.
    Lancet. 2022 Feb 28. pii: S0140-6736(22)00335.
    

    >> Share

    
    
29. BODEN WE, Kaski JC, Al-Lamee R, Weintraub WS, et al
    What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?
    Lancet. 2022;399:691-694.
    

    >> Share

    
    November 2021
30. BELLEY-COTE EP, Devereaux PJ
    PCI versus CABG for left main coronary artery disease: is the jury still out?
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02491.
    

    >> Share

    
    
31. VAN BOVEN WJ, de Groot JR, Kluin J
    A short cut to prevent postoperative atrial fibrillation.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02435.
    

    >> Share

    
    
32. MEHRAN R, Owen R, Chiarito M, Baber U, et al
    A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02326.
    

    >> Share

    
    
33. SABATINE MS, Bergmark BA, Murphy SA, O'Gara PT, et al
    Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
    Lancet. 2021 Nov 12. pii: S0140-6736(21)02334.
    

    >> Share

    
    
34. JOVIN TG, Nogueira RG, Lansberg MG, Demchuk AM, et al
    Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)01341.
    

    >> Share

    
    
35. DIPPEL D, Roozenbeek B
    Late thrombectomy for ischaemic stroke.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02097.
    

    >> Share

    
    
36. KANG J, Koo BK, Park KW, Shin ES, et al
    Aspirin versus clopidogrel after percutaneous coronary intervention - Authors' reply.
    Lancet. 2021;398:1685-1686.
    

    >> Share

    
    
37. PAREEK M, Byrne C
    Aspirin versus clopidogrel after percutaneous coronary intervention.
    Lancet. 2021;398:1685.
    

    >> Share

    
    
38. XU B, Tu S, Song L, Jin Z, et al
    Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02248.
    

    >> Share

    
    October 2021
39. KIM CJ, Park MW, Kim MC, Choo EH, et al
    Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised tr
    Lancet. 2021;398:1305-1316.
    

    >> Share

    
    September 2021
40. TULAMO R, Venermo M
    Intervention for asymptomatic carotid artery stenosis.
    Lancet. 2021;398:1025-1027.
    

    >> Share

    
    August 2021
41. HALLIDAY A, Bulbulia R, Bonati LH, Chester J, et al
    Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy.
    Lancet. 2021 Aug 27. pii: S0140-6736(21)01910.
    

    >> Share

    
    July 2021
42. MOSS JG, Wu O, Bodenham AR, Agarwal R, et al
    Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial.
    Lancet. 2021;398:403-415.
    

    >> Share

    
    
43. TAXBRO K, Chopra V
    Appropriate vascular access for patients with cancer.
    Lancet. 2021;398:367-368.
    

    >> Share

    
    May 2021
44. KOO BK, Kang J, Park KW, Rhee TM, et al
    Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)01063.
    

    >> Share

    
    
45. AZIZI M, Sanghvi K, Saxena M, Gosse P, et al
    Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)00788.
    

    >> Share

    
    April 2021
46. GALLI M, Benenati S, Capodanno D, Franchi F, et al
    Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Lancet. 2021;397:1470-1483.
    

    >> Share

    
    
47. SIBBING D, Kastrati A
    Guided P2Y12 inhibitor therapy after percutaneous coronary intervention.
    Lancet. 2021;397:1423-1425.
    

    >> Share

    
    
48. RICKARD CM, Marsh NM, Larsen EN, McGrail MR, et al
    Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trial.
    Lancet. 2021;397:1447-1458.
    

    >> Share

    
    March 2021
49. LONNEBAKKEN MT
    The risk of no risk in STEMI.
    Lancet. 2021;397:1039-1040.
    

    >> Share

    
    
50. FIGTREE GA, Vernon ST, Hadziosmanovic N, Sundstrom J, et al
    Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Lancet. 2021;397:1085-1094.
    

    >> Share

    
    October 2020
51. TAKAHASHI K, Serruys PW, Fuster V, Farkouh ME, et al
    Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNT
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32114.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share